Pharmaceuticals, Biotechnology and Life Sciences
Collaboration adds additional program focused on HPK1 inhibitors, potential medicines that could restore proper immune system activity in multiple tumor…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S.…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of…
Dexpramipexole demonstrated significant reduction of eosinophil levels in blood and inflamed tissues PITTSBURGH–(BUSINESS WIRE)–#ALS–Knopp Biosciences LLC, a privately held drug…
Glenmark Pharmaceuticals got the final approval by the US FDA for its Ranolazine Extended-Release Tablets, generic version of Gilead’s Ranexa.
Providing researchers with an automated solution for two-step nucleic acid sample preparation DARESBURY, England–(BUSINESS WIRE)–Arcis Biotechnology (“Arcis”), the nucleic acid…
Karolinska Development’s drug developer Dilafor AB, focused on tafoxiparin for obstetric indications, has enrolled the first subject in its Phase 2b study with tafoxiparin in pregnant women planned for labor induction, Karolinska said Tuesday in a press release.
“The SWIFF-CAR system does precisely that, representing a major breakthrough in our ongoing efforts to develop innovative applications to treat a range of diseases, including cancer and autoimmune diseases.”
Dr. Reddy’s Laboratories today announced the launch of an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended Release Tablets
LONDON–(BUSINESS WIRE)–EMMAC Life Sciences Ltd, the European independent medical cannabis company, is pleased to announce that it has formed a…